InvestorsHub Logo
Followers 40
Posts 3318
Boards Moderated 0
Alias Born 08/18/2009

Re: None

Friday, 01/27/2017 4:35:36 PM

Friday, January 27, 2017 4:35:36 PM

Post# of 8449
The company said on the call last week that "out licensing" was their intention, not an outright sale. If that's the case, I fear a deal may not come before the NDA is approved. Thoughts? I initially took a speculative position here as I thought a sale would be pursued, but sounds like they won't flip this particular drug. In which case, while it still could make for a compelling investment, the timelines are completely different.